InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 04/29/2019 2:50:43 PM

Monday, April 29, 2019 2:50:43 PM

Post# of 561
News: $CBIO Catalyst Biosciences & Mosaic Biosciences Present Preclinical Data on Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration

A single intravitreal injection of 125 μg CB 2782-PEG achieved complete, rapid and sustained pharmacodynamic inhibition (>99%) of complement factor 3 (C3) in non-human primates (NHP), supporting dosing three to four times a year Data support CB 2782-PEG’s potential as...

Got this from https://marketwirenews.com/news-releases/catalyst-biosciences-mosaic-biosciences-present-preclinical-data-on-pegylated-cb-2782-for-the-treatment-of-dry-age-related-macular-degeneration-8074858.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CBIO News